November 22, 2013

Time to Kill The Foreign Pill!

Back in 2003, George Washington University started the GWU India Project, a project that gave dramatic insights into how the 'business' of lobbying works to a nation's detriment. Private companies and associations were found to be the funding entities for R&D and consulting; and in turn, these entities got public policy and judicial decisions fabricated and influenced to their benefit with respect to Intellectual Property (IP). Many views on critical agendas were deliberately made one-sided, in favour of these so called funding entities. Various US lobbyists were part of these efforts and tried to manipulate decisions and views of many Indian lawmakers and thought leaders.

Foreign Pharma has always kept a close eye on Indian pharmaceutical manufacturers and related drug legislations, especially as most of our manufacturers are infamous for producing low cost generic unbranded drugs, whose branded versions are being sold at prices that are phenomenally high and out of reach of those millions of Indians who are waiting for lifesaving drugs and struggling with treatable diseases. And this generic drugs clearly work to the detriment of foreign pharma companies.

Consequently, US pharma giants have been continually lobbying politically with their government to pressurise the Indian government to insert a cap on permits that are issued to domestic companies for making low-cost copies of patented drugs. Even companies like Pfizer and Merck met the Department of Industrial Policy & Promotion (DIPP) to lobby against compulsory licenses being issued by India. For the uninitiated, a compulsory licence is a permission issued to any local manufacturer allowing him to produce the so-called ‘copied versions’ of patented medicines without any prior permission of the original patent owner. For instance, Novartis’ anti-leukemia drug Glivec costs an unaffordable Rs. 1.2 lakh per month, while its generic formulation, made by domestic manufacturers, costs nothing more than Rs. 8,000. In another similar case, in March 2012, India’s Patent Controller issued a compulsory license to an Indian generic manufacturer to produce Sorafenib Tosylate, which was being sold by Bayer for $4500 per person per month in India as kidney and liver cancer medicine.

Read more

Share/Bookmark

5 comments:

Brad maddox said...

great

Dibyojyoti said...

Some gifts just come and go, but the Gifts crafted with inner emotions stay forever. Special relations always occupy special place in heart, and deserves special gifts of Cake and Chocolate to pay tribute to them. Be it flowers, be it foods, be it something else, your gifts are your identity.

radha mohan said...

I read your awesome blog. I really like this blog. If anyone wants to enjoy in Sikkim then come with us and get Tour package to Sikkim in Unbeatable price.

Avash Roy said...

“Jingle bells” song reminds us about the arrival of Christmas. And Christmas means Gifts and fun. This Christmas present your family, friends and close acquaintances living in Brazil with gifts from us specialized for delivery to Brazil. Flowers along with Cakes, Cookies and Chocolates are the perfect excellence as offered by nature to convey our thoughts and emotions to the right place in the right manner.

Manoj Kusshwaha said...

great rhyme love it

" This blog is managed by The Sunday Indian. We heartily welcome comments on the articles.. However TSI will delete all those comments which are personal in nature and have the usage of unparliamentary language. "